Loading organizations...
Aweida Venture Partners operates as a venture capital firm, building a portfolio of technology and life sciences companies. The firm focuses its capital on seed-stage and mezzanine opportunities across data storage, software, and life sciences. As a $100 million evergreen fund, it maintains flexibility, allowing for sustained engagement and development of innovative solutions within its specialized domains.
Established in 1988, Aweida Venture Partners was founded by Jesse I. Aweida, who serves as a Managing Partner. The firm’s inception was driven by an early understanding of potential within specific high-tech and scientific sectors. Jesse Aweida’s expertise enabled the identification and cultivation of early-stage companies poised for substantial impact in data infrastructure and biotechnology.
The firm primarily serves nascent technology and life science companies requiring growth capital. Aweida Venture Partners' vision is to catalyze innovation and technological progress by backing promising enterprises. Investing strategically in data storage, software, and life sciences, the firm seeks to contribute to the evolution of key industries, fostering long-term value creation for its portfolio.
Aweida Venture Partners has 5 tracked investments across 2 companies. The latest tracked deal is $4.0M Seed in Alchemy IoT in December 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 13, 2017 | Alchemy IoT | $4.0M Seed | Aweida Venture Partners | — |
| Jun 12, 2017 | Vertos Medical | $28.0M Other Equity | Hugo Harrod | Leerink Revelation Partners, ONSET Ventures, Pitango Venture Capital |
| Jun 1, 2017 | Vertos Medical | $28.0M Series U | MVM Partners | Pitango Venture Capital, Leerink Revelation Partners, ONSET Ventures |
| Jun 1, 2013 | Vertos Medical | $23.0M Series E | Pitango Venture Capital | CHL Medical Partners, Foundation Medical Partners, Mercury Fund, ONSET Ventures |
| Oct 1, 2009 | Vertos Medical | $16.0M Series D | ONSET Ventures | Mercury Fund, CHL Medical Partners, DFJ Mercury, Foundation Medical Partners |